Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : M008
Therapeutic Area : Endocrinology
Study Phase : Preclinical
Recipient : MRM Health
Deal Size : Undisclosed
Deal Type : Collaboration
MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program
Details : MRM Health, working in conjunction with International Flavors & Fragrances, is advancing the LBP candidate M008 for treating NAFLD/NASH. The proprietary MRM Health CORAL® technology platform and some IFF strains will be combined to develop novel therape...
Product Name : Undisclosed
Product Type : Microorganism
Upfront Cash : Undisclosed
December 12, 2022
Lead Product(s) : M008
Therapeutic Area : Endocrinology
Highest Development Status : Preclinical
Recipient : MRM Health
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Phosphatidylserine
Therapeutic Area : Neurology
Study Phase : Undisclosed
Recipient : Northumbria University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 05, 2022
Lead Product(s) : Phosphatidylserine
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Recipient : Northumbria University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Gut-Microbiome
Therapeutic Area : Gastroenterology
Study Phase : Discovery
Recipient : Rutgers University
Deal Size : Undisclosed
Deal Type : Collaboration
DuPont Nutrition & Biosciences Announces Research Collaboration with Rutgers University
Details : The two-year research partnership will focus on improving the benefit/risk ratio of chemotherapy by decreasing gut inflammation caused by chemotherapy to potentially improve response rates through modulation of the microbiome.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Undisclosed
July 23, 2020
Lead Product(s) : Gut-Microbiome
Therapeutic Area : Gastroenterology
Highest Development Status : Discovery
Recipient : Rutgers University
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Recipient : MRM Health
Deal Size : $15.1 million
Deal Type : Collaboration
DuPont Nutrition & Biosciences Enters into Collaboration
Details : In collaboration, proprietary MRM Health technology platform and some selected DuPont strains will be combined to develop novel therapeutics based on live bacterial strain combinations.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 19, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Recipient : MRM Health
Deal Size : $15.1 million
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II
Recipient : Swinburne University of Technology
Deal Size : Inapplicable
Deal Type : Inapplicable
Examining the Effects of One-Month Probiotic Treatment on Mental Fatigue
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 02, 2018
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Recipient : Swinburne University of Technology
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Neurology
Study Phase : Undisclosed
Recipient : Northumbria University
Deal Size : Inapplicable
Deal Type : Inapplicable
The Cognitive Effects of 6 Weeks Administration With a Probiotic
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
July 26, 2018
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Recipient : Northumbria University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lpc-37
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Recipient : Daacro
Deal Size : Inapplicable
Deal Type : Inapplicable
Stress & Anxiety Dampening Effects of a Probiotic Supplement Compared to Placebo in Healthy Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 11, 2018
Lead Product(s) : Lpc-37
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Recipient : Daacro
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Probion Clinica
Therapeutic Area : Oncology
Study Phase : Undisclosed
Recipient : Vastra Gotaland Region
Deal Size : Inapplicable
Deal Type : Inapplicable
Using Probiotics to Reactivate Tumor Suppressor Genes in Colon Cancer
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
March 07, 2017
Lead Product(s) : Probion Clinica
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Recipient : Vastra Gotaland Region
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Acidophilus
Therapeutic Area : Immunology
Study Phase : Phase II
Recipient : Connecticut Children's Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 31, 2015
Lead Product(s) : Lactobacillus Acidophilus
Therapeutic Area : Immunology
Highest Development Status : Phase II
Recipient : Connecticut Children's Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Colorado Diet
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : University of Colorado, Denver
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Soy Protein and Colorado Diet on Weight Loss and Maintenance
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 05, 2015
Lead Product(s) : Colorado Diet
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : University of Colorado, Denver
Deal Size : Inapplicable
Deal Type : Inapplicable